HOUSTON, Feb. 22, 2021 /PRNewswire/ -- Soliton, Inc.,
(Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary platform technology, today
announced that the Company is scheduled to release its fourth
quarter and full year 2020 financial results on Thursday, March 4, 2021, after the market
closes.
Soliton will host a conference call which will include a live
presentation on Thursday, March 4,
2021, at 4:30 p.m. ET to
discuss the results. The dial-in numbers for the conference call
are (833) 423-0479 for domestic callers and (918) 922-2373 for
international callers. The conference ID number is 7559148.
We encourage participants to view the live webcast of the call,
which will feature an updated investor presentation, and will be
available on the Investor Relations page of the Soliton, Inc.
website, https://www.soliton.com/. A replay of the webcast will be
archived on Soliton's website for 30 days following the completion
of the call.
In addition, a telephonic replay of the call will be available
until March 11, 2021. The replay
dial-in numbers are (855) 859-2056 for domestic callers and (404)
537-3406 for international callers. Please use the replay
conference ID number 7559148.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer
Center. The Company's first FDA cleared commercial product will use
rapid pulses of acoustic shockwaves as an accessory to lasers for
the removal of unwanted tattoos and the treatment of cellulite. The
Company is based in Houston,
Texas, and is actively engaged in bringing the Rapid
Acoustic Pulse ("RAP") device to the market. The Company believes
this "Soliton" method has the potential to lower tattoo removal
costs for patients, while increasing profitability to
practitioners, compared to current laser removal methods. Soliton
is investigating potential additional capabilities of the RAP
technology. The device is currently cleared in the United States only for use in tattoo
removal and cellulite.
For more information about the Company, please visit:
http://www.soliton.com
Forward-Looking Statements
Some of the statements in this release are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934 and the
Private Securities Litigation Reform Act of 1995, which involve
risks and uncertainties. These statements relate to future events,
future expectations, plans and prospects. Although Soliton believes
that the expectations reflected in such forward-looking statements
are reasonable as of the date made, expectations may prove to have
been materially different from the results expressed or implied by
such forward-looking statements. Soliton has attempted to identify
forward-looking statements by terminology including ''believes,''
''estimates,'' ''anticipates,'' ''expects,'' ''plans,''
''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,''
''might,'' ''will,'' ''should,'' ''approximately'' or other words
that convey uncertainty of future events or outcomes to identify
these forward-looking statements. These statements are only
predictions and involve known and unknown risks, uncertainties, and
other factors, including those discussed under in our SEC filings,
including under the heading "Item 1A. Risk Factors" in the Form
10-K for year ended December 31, 2019
we filed with the SEC on March 2,
2020 and updated from time to time in our Form 10-Q filings
and in our other public filings with the SEC. Any
forward-looking statements contained in this release speak only as
of its date. Soliton undertakes no obligation to update any
forward-looking statements contained in this release to reflect
events or circumstances occurring after its date or to reflect the
occurrence of unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-4-2021-301231053.html
SOURCE Soliton, Inc.